Clinical trial NCT04947527: Efficacy and Safety Evaluation of Anti-Caries Varnish
Official title: Phase 2 Efficacy & Safety Evaluation of Advantage Anti-Caries Varnish for Primary Prevention
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: Dental Caries in Children
Keywords: sodium fluoride
povidone iodine
dental varnish
primary dentition
Lead sponsor: Advantage Silver Dental Arrest, LLC
Sponsor class: INDUSTRY
First posted: 2021-07-01
Enrollment: 274
Sex: ALL
Minimum age (years): 10
Maximum age (years): 20
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: This is a single center randomized, double-blind, placebo-controlled, parallel-group trial.
Primary purpose: PREVENTION

Brief summary: The purpose of the study is to determine the efficacy \& safety of Advantage Anti-Caries Varnish for primary prevention. The objectives are:

1) To determine if Advantage Anti-Caries Varnish (test varnish) is superior to an active control varnish (5% Sodium Fluoride, no Povidone-Iodine) in the prevention of caries lesions in the primary dentition. Specifically, prevention of caries lesions in primary teeth that either are sound, have only d1 (white spots) lesions or unerupted at baseline; and 2) To document the safety of the test varnish.

Detailed description: This is a single center randomized, double-blind, placebo-controlled, parallel-group trial. The treatment group will be exposed at baseline and once every three to four months after baseline for a maximum period of 24 months. The control group will be exposed to the control varnish in the same manner. 254 subjects will be enrolled. Half will be randomized to each arm. Subjects will be 6-24 mo of age and in good health. Children attending Maternal and Child Health (MCH) Immunization and Well Child programs in Pohnpei State will be enrolled. Primary Outcome Variables: 1) Surface-level dental caries lesions (d2-4mfs) at 24 months post baseline; 2) Presence/Absence of dental caries lesions (d2-4mfs \>0) at 12 months post baseline. Secondary Outcome Variable: Adverse Events

Eligibility criteria: Inclusion Criteria:

1. The subject's parent or legal guardian must provide signed and dated informed consent (parent permission form).
2. The subject's parent or legal guardian of the subject must be willing and able to comply with study requirements.
3. The subject is a 6-24 months at the time of enrollment.
4. The subject must be in good general health as evidenced by parent report.
5. The subject will have at least 1 erupted tooth that is either sound or has only a d1 (white spots) lesion.

Exclusion Criteria:

1. Previous treatment with fluoride varnish
2. Known allergy to iodine
3. Diagnosis of thyroid disease
4. Chronic, prophylactic use of antibiotics
5. Treatment with another investigational drug or intervention within 30 days preceding the Baseline Visit.
6. Visible cavities (d2-4)
7. Presence of intraoral pathology that would make assessment of post treatment soft tissue ulcerations or inflammation impossible (child could be enrolled if problem is treated and lesions cleared)
8. Parent anticipates the child will move from Pohnpei during the next 2 years.

Primary outcomes:
measure: Caries Increment
timeFrame: 24 months post baseline
measure: Caries Incidence
timeFrame: 12 months post baseline
Secondary outcomes:
measure: Adverse Events
timeFrame: 24 months post baseline
Other outcomes:
Locations:
city: Pohnpei
country: United States Minor Outlying Islands
facility: Pohnpei State Hospital
state: FSM
Study officials:
affiliation: University of Washington
name: Ohnmar K Tut, BDS Phil
role: PRINCIPAL_INVESTIGATOR
References: